Remove Manufacturing Remove Pharmaceutical Remove Sales
article thumbnail

In Brain Chemistry We Trust—The Gospel According to Pharma

Mad in America

Depression was sold to us as a simple problem of serotonin insufficiency, a convenient narrative that made drug companies like Eli Lilly, Forest Pharmaceuticals, and Pfizer very rich. As a former pharmaceutical advertising writer, I not only witnessed the explosive growth in antidepressant drugs, I contributed to it.

article thumbnail

Confessions of an Ad Writer: How I Helped Turn Atypical Antipsychotics into a Billion-Dollar Industry

Mad in America

I was just a copywriter working in pharmaceutical advertising. The rise of atypical antipsychotics was a business and marketing phenomenon—driven in part by a wave of pharmaceutical mergers in the 1990s. I didn’t set out to shape the field of psychiatry. The agency was in Midtown Manhattan. The client was Johnson & Johnson.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How buyers can successfully navigate integrating a carve-out

McKensey

For example, when an acquirer forgot to update its insurance policy following a deal close, the target’s sales force members could no longer drive their cars to customer meetings. For example, a pharmaceutical company and SMO established a close collaboration model, including shared locations, daily touchpoints, and full-day workshops.

article thumbnail

A kaleidoscope approach to leading: Five perspective shifts that can foster innovation

Work Life

In Tony’s work as a leadership coach, he worked with a pharmaceutical CEO who realized that her company’s long-term vision had become blurred. A manufacturing department head we worked with struggled with operational inefficiencies. We worked on refining her vision, focusing on sustainability and innovation.

article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Six)

Mad in America

693 This made the journal’s editor, Marcia Angell, publish an accompanying editorial: “Is academic medicine for sale?” Avoid financial conflicts of interest with manufacturers of psychoactive drugs or other treatments, e.g. equipment for electroshock. This showed that the whole specialty has been corrupted by industry money.

article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. The marketing of medical conditions has become a key plank of pharmaceutical industry marketing. Helping widen the definitions of disease is a key part of marketing those pharmaceutical products.

article thumbnail

Adjusted Community Rating and Its Role in Health Care Costs

Insperity

Medical device sales tax – this tax on the sale of certain taxable medical devices will indirectly increase health insurance costs as manufacturers raise prices to cover the tax. Pharmaceutical manufacturer excise tax – annual fee on entities engaged in the business of manufacturing or importing branded prescription drugs.